Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
GoFreshRx is a randomized trial, testing the effects of a home-delivered DASH-patterned grocery intervention on blood pressure in Black adults actively treated for hypertension, residing in Boston area urban food deserts.
Full description
Hypertension affects over half of Black adults in the United States - more than any other group - and diet is a principal determinant of disparities in hypertension among Black adults. While the DASH diet is a proven strategy for lowering blood pressure in Black adults, diet disparities are increasing in urban food deserts due to poor access and the high costs of healthy foods. Our proposed clinical trial will randomize 150 Black adults, who are actively treated for hypertension and reside in Boston area urban food deserts to either:
12 weeks of dietitian-assisted, DASH grocery delivery via an online, virtual grocery store at an amount sufficient to replace all Calorie needs of each participant, allowing for some sharing with family members
or
Self-directed shopping with a monthly stipend over a 3-month period
After the 12-week intervention phase, participants will undergo a 9-month observation phase. At 3-months after the intervention is complete the investigators will repeat in-person study assessments and perform qualitative interviews in a subset of the population to determine barriers and facilitators to intermediate-term maintenance of the intervention. At 9-months after the intervention, participants will participate in a phone visit designed to assess longer-term maintenance of the intervention.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
INCLUSION:
EXCLUSION:
Laboratory Exclusions:
Medication Exclusions:
Unstable doses of medications that lower blood pressure or medications intended for hypertension treatment (including antihypertensives taken for non-hypertension purposes) within the last 6 months
Unstable doses (i.e. a change in the 2 months prior to screening or randomization) of the following:
Use of any of the following medications:
Unwillingness to keep same dose of vitamin, mineral, and botanical supplements
Any medication not compatible with participation as determined by the investigators
Physical Exclusions:
Medical History Exclusions:
Lifestyle and Other Exclusions:
Primary purpose
Allocation
Interventional model
Masking
150 participants in 2 patient groups
Loading...
Central trial contact
Ruth-Alma Turkson-Ocran, PhD, FNP; Stephen P Juraschek, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal